Trial intelligence / Profile preview

High-dose tranexamic acid in primary unilateral total knee arthroplasty

CTR20201081Phase 3Completed

Sponsor
Hunan Dongting Pharmaceutical
Start
Jun 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of tranexamic acid in perioperative hemorrhage, sponsored by Hunan Dongting Pharmaceutical. Started Jun 2020; status: completed.

02

Drugs

tranexamic acid
03

Conditions

perioperative hemorrhage

Beyond the preview

Go deeper on CTR20201081.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20201081.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call